Polymorphisms in immune function genes and risk of non-Hodgkin lymphoma: findings from the New South Wales non-Hodgkin Lymphoma Study
about
Common genetic variants in candidate genes and risk of familial lymphoid malignanciesRisk of lymphoproliferative disorders among first-degree relatives of lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia patients: a population-based study in SwedenTumor necrosis factor-α induced protein 8 polymorphism and risk of non-Hodgkin's lymphoma in a Chinese population: a case-control study.Lymphotoxin-alpha polymorphisms and presence of cancer in 1,536 consecutive autopsy casesCommon gene variants in the tumor necrosis factor (TNF) and TNF receptor superfamilies and NF-kB transcription factors and non-Hodgkin lymphoma riskPolymorphisms in DNA repair genes and MDR1 and the risk for non-Hodgkin lymphoma.Cytokine gene polymorphisms and progression-free survival in classical Hodgkin lymphoma by EBV status: results from two independent cohorts.Genetic susceptibility to lymphomaTumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) polymorphisms and risk of non-Hodgkin lymphoma in the InterLymph Consortium.Power of data mining methods to detect genetic associations and interactionsGermline variation in apoptosis pathway genes and risk of non-Hodgkin's lymphoma.The major histocompatibility complex conserved extended haplotype 8.1 in AIDS-related non-Hodgkin lymphomaCytokine polymorphisms in Th1/Th2 pathway genes, body mass index, and risk of non-Hodgkin lymphoma.The interleukin-10 promoter polymorphism rs1800872 (-592C>A), contributes to cancer susceptibility: meta-analysis of 16,785 cases and 19,713 controls.Genetic variation in Th1/Th2 pathway genes and risk of non-Hodgkin lymphoma: a pooled analysis of three population-based case-control studies.Lymphotoxin alpha (LTA) polymorphism is associated with prognosis of non-Hodgkin's lymphoma in a Chinese populationRisk of non-Hodgkin lymphoma associated with germline variation in genes that regulate the cell cycle, apoptosis, and lymphocyte developmentNon-Hodgkin lymphoma risk and variants in genes controlling lymphocyte developmentAssociation of the four common polymorphisms in interleukin-10 (rs1800890, rs1800896, rs1800871, and rs1800872) with non-Hodgkin's lymphoma risk: a meta-analysis.Circulating cytokines and risk of B-cell non-Hodgkin lymphoma: a prospective study.Host genetics in follicular lymphomaPolymorphisms in the TNF-α and IL10 gene promoters and risk of arsenic-induced skin lesions and other nondermatological health effects.Four genetic polymorphisms of lymphotoxin-alpha gene and cancer risk: a systematic review and meta-analysis.Prediagnostic serum levels of cytokines and other immune markers and risk of non-hodgkin lymphoma.A pooled analysis of three studies evaluating genetic variation in innate immunity genes and non-Hodgkin lymphoma risk.Association of IL10 -819C>T and -592C>A Polymorphisms with Non-Hodgkin Lymphoma Susceptibility: Evidence from Published StudiesCorrelation analysis of gene polymorphisms and β-lactam allergy.Polymorphisms in complement system genes and risk of non-Hodgkin lymphomaInherited Inflammatory Response Genes Are Associated with B-Cell Non-Hodgkin's Lymphoma Risk and Survival.A two-stage evaluation of genetic variation in immune and inflammation genes with risk of non-Hodgkin lymphoma identifies new susceptibility locus in 6p21.3 region.Occupational solvent exposure, genetic variation in immune genes, and the risk for non-Hodgkin lymphomaIL-10 -1082 SNP and IL-10 in primary CNS and vitreoretinal lymphomas.Pretreatment circulating serum cytokines associated with follicular and diffuse large B-cell lymphoma: a clinic-based case-control studyAssociation between tumor necrosis factor-α gene polymorphisms and diffuse large B-cell lymphoma in Chinese Han population: evidence from two center case-control study and a meta-analysis.Genetic variation in 1253 immune and inflammation genes and risk of non-Hodgkin lymphoma.Smoking, variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2), and risk of non-Hodgkin lymphoma: a pooled analysis within the InterLymph consortium.Non-hodgkin lymphoma and circulating markers of inflammation and adiposity in a nested case-control study: the multiethnic cohort.Tumor necrosis factor-308 polymorphism with the risk and prognosis of non-Hodgkin lymphomas: a meta-analysis studyThe interleukin 10 -819C/T polymorphism and cancer risk: a HuGE review and meta-analysis of 73 studies including 15,942 cases and 22,336 controls.Host immune gene polymorphisms in combination with clinical and demographic factors predict late survival in diffuse large B-cell lymphoma patients in the pre-rituximab era
P2860
Q24630753-9DD66EFA-E8EE-4A26-9DCD-3D8EAB6D100FQ28290841-76442D9B-056C-425A-AECD-9CCDCAA7AF43Q31063522-D40DDFC0-C699-472F-947A-6F8CEA98DB1FQ33359870-D467D235-3D3A-4DFE-88D4-D98BA9E482B4Q33434511-23D67600-0256-4250-9E8A-E0AAE5B3FDE1Q33580765-033CC956-8EE0-40C5-B1B8-DF1651247646Q33598099-498A317C-8664-433A-8CCB-C1E95D13DC5EQ33641328-97AE49BB-1520-4912-8959-24CB88D5DE5AQ33741481-C4352917-B2C8-427D-88A6-66A5B260B7AFQ34024897-D45B0502-D0AE-498A-A598-9E74750DB293Q34292891-FA43316D-1D6B-41F6-9B5B-2AD6257400B7Q34462958-6C328959-6EB4-4A76-9E63-C90D65ECBC82Q34542117-3C15DE2B-A0DC-4315-9A97-0BC201A383A4Q34608463-465CE447-E252-49B9-A4B5-A13760E07D48Q34785970-FC459A11-5F9C-4834-B3D2-CFCF30193FE2Q34805375-D0E6298A-A525-4D51-917B-A3DB6EEF35E6Q34972303-AE496FF7-7D0B-4B9D-B351-7BE1603A9874Q35009957-445C8D1C-B506-4CD8-A3A4-100380D1FF58Q35016930-997CDEE7-2AA0-411F-98CA-E48BB549292BQ35034487-70A2610D-652E-4FF9-9F2A-5B51D759E3C5Q35038312-94B0EA1B-4B1B-49A3-A65A-140C8AB71426Q35047089-8519C833-E687-4DC6-87B5-A8BFC92C350EQ35070335-748D9286-5FA1-4473-B60F-6BB2643F2F91Q35112864-F976235D-EB78-47BB-B512-EDDEB503FA09Q35660939-BDC8FE50-5337-4234-BF83-4CD397802F2CQ35856831-CE63DFDA-9822-44EE-9BB1-0CD108D5884FQ35864849-FAE59AB4-C0D1-4204-81B5-7910D5C77232Q36081383-2EEE25B5-EBF2-44AA-B3C1-1457853CB7E7Q36137122-E00E63A6-6B6C-43C5-8FF7-0692725ADA4BQ36306403-6DF0FCF0-59D6-4666-9AC0-EC24DA045419Q36312968-A290D2F1-0289-491D-9225-1DE43250337EQ36312982-85850F13-523E-4FF2-8313-F4B8FF7D49ABQ36354265-7716CF63-C648-4D4D-B568-888395321710Q36375294-64A7901D-F44D-412E-897B-9EBA0EDE2FDEQ36447972-34C871E3-C945-44C2-BFCE-F443E32FF24EQ36487605-2D3CDF70-CAE1-4AF7-A25F-3E922C97B6D4Q36680965-6DCCD9C7-72D1-495A-BA44-E8489F6868A1Q36729256-3F24CA56-35A6-49D2-800A-6CE36C3387DBQ36737978-4563E7A0-BF31-4013-81C5-32E5C991263DQ36915855-22901964-E52B-496C-A8FF-CFB4E6E1CF16
P2860
Polymorphisms in immune function genes and risk of non-Hodgkin lymphoma: findings from the New South Wales non-Hodgkin Lymphoma Study
description
article
@en
im März 2007 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в березні 2007
@uk
name
Polymorphisms in immune functi ...... les non-Hodgkin Lymphoma Study
@en
Polymorphisms in immune functi ...... les non-Hodgkin Lymphoma Study
@nl
type
label
Polymorphisms in immune functi ...... les non-Hodgkin Lymphoma Study
@en
Polymorphisms in immune functi ...... les non-Hodgkin Lymphoma Study
@nl
prefLabel
Polymorphisms in immune functi ...... les non-Hodgkin Lymphoma Study
@en
Polymorphisms in immune functi ...... les non-Hodgkin Lymphoma Study
@nl
P2093
P50
P356
P1433
P1476
Polymorphisms in immune functi ...... les non-Hodgkin Lymphoma Study
@en
P2093
Andrew E. Grulich
Anne Kricker
Denise Whitby
Mark P. Purdue
P304
P356
10.1093/CARCIN/BGL200
P407
P577
2007-03-01T00:00:00Z